Selected research
Industry Research
Cryptococcosis Industry Research Report 2026
Market perspective
The global Cryptococcosis market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Cryptococcosis is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Cryptococcosis is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Cryptococcosis is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Cryptococcosis include Bausch Health, Bristol-Myers Squibb, Glenmark, Sigmapharm, Viamet Pharmaceuticals, Pfizer, Novartis, Johnson & Johnson and Abbott, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Cryptococcosis market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cryptococcosis Market by Company
Bausch Health
Bristol-Myers Squibb
Glenmark
Sigmapharm
Viamet Pharmaceuticals
Pfizer
Novartis
Johnson & Johnson
Abbott
Cryptococcosis Segment by Type
Voriconazole
Flucytosine (Ancobon)
Fluconazole (Diflucan)
Amphotericin B (Amphocin and Fungizone)
Cryptococcosis Segment by Application
Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
Cryptococcosis Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cryptococcosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cryptococcosis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cryptococcosis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cryptococcosis manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cryptococcosis by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cryptococcosis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Voriconazole
- Flucytosine (Ancobon)
- Fluconazole (Diflucan)
- Amphotericin B (Amphocin and Fungizone)
Applications
- Retail Pharmacies
- Online Pharmacies
- Hospital Pharmacies
Companies covered
- Bausch Health
- Bristol-Myers Squibb
- Glenmark
- Sigmapharm
- Viamet Pharmaceuticals
- Pfizer
- Novartis
- Johnson & Johnson
- Abbott
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Cryptococcosis Market Size (2021-2032)
- 2.2.2 Global Cryptococcosis Sales (2021-2032)
- 2.2.3 Global Cryptococcosis Market Average Price (2021-2032)
- 2.3 Cryptococcosis by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Voriconazole
- 2.3.3 Flucytosine (Ancobon)
- 2.3.4 Fluconazole (Diflucan)
- 2.3.5 Amphotericin B (Amphocin and Fungizone)
- 2.4 Cryptococcosis by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Retail Pharmacies
- 2.4.3 Online Pharmacies
- 2.4.4 Hospital Pharmacies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Cryptococcosis Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Cryptococcosis Sales (Kg) of Manufacturers (2021-2026)
- 3.3 Global Cryptococcosis Revenue of Manufacturers (2021-2026)
- 3.4 Global Cryptococcosis Average Price by Manufacturers (2021-2026)
- 3.5 Global Cryptococcosis Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Cryptococcosis, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Cryptococcosis, Product Type & Application
- 3.8 Global Manufacturers of Cryptococcosis, Established Date
- 3.9 Global Cryptococcosis Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Bausch Health
- 4.1.1 Bausch Health Company Information
- 4.1.2 Bausch Health Business Overview
- 4.1.3 Bausch Health Cryptococcosis Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Bausch Health Cryptococcosis Product Portfolio
- 4.1.5 Bausch Health Recent Developments
- 4.2 Bristol-Myers Squibb
- 4.2.1 Bristol-Myers Squibb Company Information
- 4.2.2 Bristol-Myers Squibb Business Overview
- 4.2.3 Bristol-Myers Squibb Cryptococcosis Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Bristol-Myers Squibb Cryptococcosis Product Portfolio
- 4.2.5 Bristol-Myers Squibb Recent Developments
- 4.3 Glenmark
- 4.3.1 Glenmark Company Information
- 4.3.2 Glenmark Business Overview
- 4.3.3 Glenmark Cryptococcosis Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Glenmark Cryptococcosis Product Portfolio
- 4.3.5 Glenmark Recent Developments
- 4.4 Sigmapharm
- 4.4.1 Sigmapharm Company Information
- 4.4.2 Sigmapharm Business Overview
- 4.4.3 Sigmapharm Cryptococcosis Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sigmapharm Cryptococcosis Product Portfolio
- 4.4.5 Sigmapharm Recent Developments
- 4.5 Viamet Pharmaceuticals
- 4.5.1 Viamet Pharmaceuticals Company Information
- 4.5.2 Viamet Pharmaceuticals Business Overview
- 4.5.3 Viamet Pharmaceuticals Cryptococcosis Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Viamet Pharmaceuticals Cryptococcosis Product Portfolio
- 4.5.5 Viamet Pharmaceuticals Recent Developments
- 4.6 Pfizer
- 4.6.1 Pfizer Company Information
- 4.6.2 Pfizer Business Overview
- 4.6.3 Pfizer Cryptococcosis Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Pfizer Cryptococcosis Product Portfolio
- 4.6.5 Pfizer Recent Developments
- 4.7 Novartis
- 4.7.1 Novartis Company Information
- 4.7.2 Novartis Business Overview
- 4.7.3 Novartis Cryptococcosis Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Novartis Cryptococcosis Product Portfolio
- 4.7.5 Novartis Recent Developments
- 4.8 Johnson & Johnson
- 4.8.1 Johnson & Johnson Company Information
- 4.8.2 Johnson & Johnson Business Overview
- 4.8.3 Johnson & Johnson Cryptococcosis Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Johnson & Johnson Cryptococcosis Product Portfolio
- 4.8.5 Johnson & Johnson Recent Developments
- 4.9 Abbott
- 4.9.1 Abbott Company Information
- 4.9.2 Abbott Business Overview
- 4.9.3 Abbott Cryptococcosis Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Abbott Cryptococcosis Product Portfolio
- 4.9.5 Abbott Recent Developments
5 Global Cryptococcosis Market Scenario by Region
- 5.1 Global Cryptococcosis Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Cryptococcosis Sales by Region: 2021-2032
- 5.2.1 Global Cryptococcosis Sales by Region: 2021-2026
- 5.2.2 Global Cryptococcosis Sales by Region: 2027-2032
- 5.3 Global Cryptococcosis Revenue by Region: 2021-2032
- 5.3.1 Global Cryptococcosis Revenue by Region: 2021-2026
- 5.3.2 Global Cryptococcosis Revenue by Region: 2027-2032
- 5.4 North America Cryptococcosis Market Facts & Figures by Country
- 5.4.1 North America Cryptococcosis Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Cryptococcosis Sales by Country (2021-2032)
- 5.4.3 North America Cryptococcosis Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Cryptococcosis Market Facts & Figures by Country
- 5.5.1 Europe Cryptococcosis Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Cryptococcosis Sales by Country (2021-2032)
- 5.5.3 Europe Cryptococcosis Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Cryptococcosis Market Facts & Figures by Country
- 5.6.1 Asia Pacific Cryptococcosis Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Cryptococcosis Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Cryptococcosis Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Cryptococcosis Market Facts & Figures by Country
- 5.7.1 South America Cryptococcosis Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Cryptococcosis Sales by Country (2021-2032)
- 5.7.3 South America Cryptococcosis Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Cryptococcosis Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Cryptococcosis Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Cryptococcosis Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Cryptococcosis Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Cryptococcosis Sales by Type (2021-2032)
- 6.1.1 Global Cryptococcosis Sales by Type (2021-2032) & (Kg)
- 6.1.2 Global Cryptococcosis Sales Market Share by Type (2021-2032)
- 6.2 Global Cryptococcosis Revenue by Type (2021-2032)
- 6.2.1 Global Cryptococcosis Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Cryptococcosis Revenue Market Share by Type (2021-2032)
- 6.3 Global Cryptococcosis Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Cryptococcosis Sales by Application (2021-2032)
- 7.1.1 Global Cryptococcosis Sales by Application (2021-2032) & (Kg)
- 7.1.2 Global Cryptococcosis Sales Market Share by Application (2021-2032)
- 7.2 Global Cryptococcosis Revenue by Application (2021-2032)
- 7.2.1 Global Cryptococcosis Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Cryptococcosis Revenue Market Share by Application (2021-2032)
- 7.3 Global Cryptococcosis Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Cryptococcosis Value Chain Analysis
- 8.1.1 Cryptococcosis Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Cryptococcosis Production Mode & Process
- 8.2 Cryptococcosis Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Cryptococcosis Distributors
- 8.2.3 Cryptococcosis Customers
9 Global Cryptococcosis Analyzing Market Dynamics
- 9.1 Cryptococcosis Industry Trends
- 9.2 Cryptococcosis Industry Drivers
- 9.3 Cryptococcosis Industry Opportunities and Challenges
- 9.4 Cryptococcosis Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst